FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

426081003: Diphtheria + tetanus + pertussis + recombinant hepatitis B virus vaccine (product)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    2662998015 Diphtheria + tetanus + pertussis + recombinant hepatitis B virus vaccine (product) en Fully specified name Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    2674866013 Diphtheria + tetanus + pertussis + recombinant hepatitis B virus vaccine en Synonym (core metadata concept) Active Only initial character case insensitive (core metadata concept) SNOMED CT core
    3501831000005112 difteri- + tetanus- + kighoste- + rekombinant hepatitis B-virus-vaccine da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    difteri- + tetanus- + kighoste- + rekombinant hepatitis B-virus-vaccine Is a rekombinant hepatitis B-virus-vaccine false Inferred relationship Some
    difteri- + tetanus- + kighoste- + rekombinant hepatitis B-virus-vaccine Is a kighostevaccine false Inferred relationship Some
    difteri- + tetanus- + kighoste- + rekombinant hepatitis B-virus-vaccine Is a difterivaccine false Inferred relationship Some
    difteri- + tetanus- + kighoste- + rekombinant hepatitis B-virus-vaccine Is a tetanusvaccine false Inferred relationship Some
    difteri- + tetanus- + kighoste- + rekombinant hepatitis B-virus-vaccine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. rekombinant vaccine mod hepatitis B-virus false Inferred relationship Some 3
    difteri- + tetanus- + kighoste- + rekombinant hepatitis B-virus-vaccine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. difterivaccine false Inferred relationship Some
    difteri- + tetanus- + kighoste- + rekombinant hepatitis B-virus-vaccine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. kighostevaccine false Inferred relationship Some 1
    difteri- + tetanus- + kighoste- + rekombinant hepatitis B-virus-vaccine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. tetanustoxoid false Inferred relationship Some
    difteri- + tetanus- + kighoste- + rekombinant hepatitis B-virus-vaccine Is a difterivaccine false Inferred relationship Some
    difteri- + tetanus- + kighoste- + rekombinant hepatitis B-virus-vaccine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. Diphtheria vaccine false Inferred relationship Some 4
    difteri- + tetanus- + kighoste- + rekombinant hepatitis B-virus-vaccine The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. tetanusvaccine false Inferred relationship Some 2
    difteri- + tetanus- + kighoste- + rekombinant hepatitis B-virus-vaccine Is a difteri- + kighoste- + tetanusvaccine false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    rekombinant hepatitis B-virusoverfladeantigenvaccine 10 µg + difteritoxoid 30 IE + tetanustoxoid 40 IE + acellulær kighostevaccine 25 µg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,5 ml Is a False difteri- + tetanus- + kighoste- + rekombinant hepatitis B-virus-vaccine Inferred relationship Some
    difteri- + tetanus- + kighoste- + polio- + rekombinant hepatitis B-virus-vaccine Is a False difteri- + tetanus- + kighoste- + rekombinant hepatitis B-virus-vaccine Inferred relationship Some
    difteri- + tetanus- + kighoste- + polio- + rekombinant hepatitis B-virus- + rekombinant Haemophilus influenzae type b-vaccine Is a False difteri- + tetanus- + kighoste- + rekombinant hepatitis B-virus-vaccine Inferred relationship Some

    Reference Sets

    Concept inactivation indicator reference set

    POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)

    Back to Start